240 related articles for article (PubMed ID: 10435724)
1. Detection of anti-LKM-1(anti-CYP2D6) by an enzyme-linked immunosorbent assay in adult patients with chronic liver diseases.
Miyakawa H; Kikazawa E; Abe K; Kikuchi K; Fujikawa H; Matsushita M; Kawaguchi N; Morizane T; Ohya K; Kako M
Autoimmunity; 1999; 30(2):107-14. PubMed ID: 10435724
[TBL] [Abstract][Full Text] [Related]
2. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
3. Differences in antigenic sites, recognized by anti-liver-kidney microsome-1 (LKM-1) autoantibody, between HCV-positive and HCV-negative sera in Japanese patients.
Miyakawa H; Matsushima H; Narita Y; Hankins RW; Kitazawa E; Fujikawa H; Kikuchi K; Matsushita M; Abe K; Kawaguchi N; Morizane T; Kako M
J Gastroenterol; 1998 Aug; 33(4):529-35. PubMed ID: 9719237
[TBL] [Abstract][Full Text] [Related]
4. Immunoreactivity to various human cytochrome P450 proteins of sera from patients with autoimmune hepatitis, chronic hepatitis B, and chronic hepatitis C.
Miyakawa H; Kitazawa E; Kikuchi K; Fujikawa H; Kawaguchi N; Abe K; Matsushita M; Matsushima H; Igarashi T; Hankins RW; Kako M
Autoimmunity; 2000; 33(1):23-32. PubMed ID: 11204250
[TBL] [Abstract][Full Text] [Related]
5. Overlapping but distinct specificities of anti-liver-kidney microsome antibodies in autoimmune hepatitis type II and hepatitis C revealed by recombinant native CYP2D6 and novel peptide epitopes.
Klein R; Zanger UM; Berg T; Hopf U; Berg PA
Clin Exp Immunol; 1999 Nov; 118(2):290-7. PubMed ID: 10540193
[TBL] [Abstract][Full Text] [Related]
6. Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment.
Dalekos GN; Wedemeyer H; Obermayer-Straub P; Kayser A; Barut A; Frank H; Manns MP
J Hepatol; 1999 Mar; 30(3):366-75. PubMed ID: 10190716
[TBL] [Abstract][Full Text] [Related]
7. Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection.
Ma Y; Peakman M; Lobo-Yeo A; Wen L; Lenzi M; Gäken J; Farzaneh F; Mieli-Vergani G; Bianchi FB; Vergani D
Clin Exp Immunol; 1994 Jul; 97(1):94-9. PubMed ID: 8033426
[TBL] [Abstract][Full Text] [Related]
8. A major CYP2D6 autoepitope in autoimmune hepatitis type 2 and chronic hepatitis C is a three-dimensional structure homologous to other cytochrome P450 autoantigens.
Sugimura T; Obermayer-Straub P; Kayser A; Braun S; Loges S; Alex B; Lüttig B; Johnson EF; Manns MP; Strassburg CP
Autoimmunity; 2002 Dec; 35(8):501-13. PubMed ID: 12765476
[TBL] [Abstract][Full Text] [Related]
9. A new approach to cytochrome CYP2D6 antibody detection in autoimmune hepatitis type-2 (AIH-2) and chronic hepatitis C virus (HCV) infection: a sensitive and quantitative radioligand assay.
Yamamoto AM; Johanet C; Duclos-Vallee JC; Bustarret FA; Alvarez F; Homberg JC; Bach JF
Clin Exp Immunol; 1997 Jun; 108(3):396-400. PubMed ID: 9182882
[TBL] [Abstract][Full Text] [Related]
10. Interferon therapy in LKM-1 positive patients with chronic hepatitis C: follow-up by a quantitative radioligand assay for CYP2D6 antibody detection.
Duclos-Vallée JC; Nishioka M; Hosomi N; Arima K; Leclercq A; Bach JF; Yamamoto AM
J Hepatol; 1998 Jun; 28(6):965-70. PubMed ID: 9672171
[TBL] [Abstract][Full Text] [Related]
11. Effect of interferon therapy on Japanese chronic hepatitis C virus patients with anti-liver/kidney microsome autoantibody type 1.
Iijima Y; Kato T; Miyakawa H; Ogino M; Mizuno M; Sugihara K; Ando T; Fujiwara K; Orito E; Ueda R; Mizokami M
J Gastroenterol Hepatol; 2001 Jul; 16(7):782-8. PubMed ID: 11446887
[TBL] [Abstract][Full Text] [Related]
12. Anti-LKM-1 antibodies determined by use of recombinant P450 2D6 in ELISA and western blot and their association with anti-HCV and HCV-RNA.
Seelig R; Renz M; Bünger G; Schröter H; Seelig HP
Clin Exp Immunol; 1993 Jun; 92(3):373-80. PubMed ID: 8390333
[TBL] [Abstract][Full Text] [Related]
13. Increased incidence of anti-LKM autoantibodies in a consecutive cohort of hepatitis C patients from central Greece.
Dalekos GN; Makri E; Loges S; Obermayer-Straub P; Zachou K; Tsikrikas T; Schmidt E; Papadamou G; Manns MP
Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):35-42. PubMed ID: 11782573
[TBL] [Abstract][Full Text] [Related]
14. A new epitope of CYP2D6 recognized by liver kidney microsomal autoantibody from japanese patients with autoimmune hepatitis.
Imaoka S; Obata N; Hiroi T; Osada-Oka M; Hara R; Nishiguchi S; Funae Y
Biol Pharm Bull; 2005 Dec; 28(12):2240-3. PubMed ID: 16327157
[TBL] [Abstract][Full Text] [Related]
15. Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1.
Manns MP; Johnson EF; Griffin KJ; Tan EM; Sullivan KF
J Clin Invest; 1989 Mar; 83(3):1066-72. PubMed ID: 2466049
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis C virus-related chronic liver disease with autoantibodies to liver-kidney microsomes (LKM). Clinical characterization from idiopathic LKM-positive disorders.
Todros L; Touscoz G; D'Urso N; Durazzo M; Albano E; Poli G; Baldi M; Rizzetto M
J Hepatol; 1991 Jul; 13(1):128-31. PubMed ID: 1655868
[TBL] [Abstract][Full Text] [Related]
17. Heterogeneity of liver/kidney microsomal antibody type 1 in autoimmune hepatitis and hepatitis C virus related liver disease.
Muratori L; Lenzi M; Ma Y; Cataleta M; Mieli-Vergani G; Vergani D; Bianchi FB
Gut; 1995 Sep; 37(3):406-12. PubMed ID: 7590439
[TBL] [Abstract][Full Text] [Related]
18. LKM-1 sera from autoimmune hepatitis patients that recognize ERp57, carboxylesterase 1 and CYP2D6.
Komurasaki R; Imaoka S; Tada N; Okada K; Nishiguchi S; Funae Y
Drug Metab Pharmacokinet; 2010; 25(1):84-92. PubMed ID: 20208391
[TBL] [Abstract][Full Text] [Related]
19. Cytochromes P450 and uridine triphosphate-glucuronosyltransferases: model autoantigens to study drug-induced, virus-induced, and autoimmune liver disease.
Manns MP; Obermayer-Straub P
Hepatology; 1997 Oct; 26(4):1054-66. PubMed ID: 9328334
[TBL] [Abstract][Full Text] [Related]
20. Absence of LKM-1 antibody reactivity in autoimmune and hepatitis-C-related chronic liver disease in Sweden. Swedish Internal Medicine Liver club.
Lindgren S; Braun HB; Michel G; Nemeth A; Nilsson S; Thome-Kromer B; Eriksson S
Scand J Gastroenterol; 1997 Feb; 32(2):175-8. PubMed ID: 9051879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
